Tevogen Statistics
NASDAQ: TVGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.68+0.19 (+2.93%)
Market open · Delayed 15 min · as of Oct 8, 9:30 AM ET
Tevogen by the numbers
Tevogen has a market capitalization of $43.5 million based on 6.51M shares outstanding. With trailing EPS of $-6.74, Tevogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.1% below its 50-day average and 27.1% below its 200-day average.
Average daily trading volume is 9.75K shares, or about $65,117 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TVGN valuation vs. peer median
| Metric | TVGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $43.50M | $41.31M | +5% |
| Avg. volume | 9.75K | 138.05K | -93% |
Peer median across 8 companies: BSEM, CVM, TIL, MGX, ELUT, GNTA, INMB, EXOZ.
Valuation
- Market cap
- $43.50M
- EPS (TTM)
- $-6.74
- Shares outstanding
- 6.51M
Price and trading
- Previous close
- 6.49
- Open
- 6.68
- Day range
- 6.68 – 6.68
- 52-week range
- 3.64 – 39.00
- 52-week change
- -82.51%
- Beta
- —
- Volume
- 310
- Average volume
- 9.75K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 43.50M
- Eps
- -6.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.00
- Week52 Low
- 3.64
- Avg Volume
- 9,748.00
- Shares Outstanding
- 6.51M
- Ma50
- 6.97
- Ma200
- 9.16
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -82.87%
- Pct From52w Low
- 83.72%